The Nobel Assembly at Karolinska Institutet has decided to award the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth, Peter Hegemann, and Georg Nagel “for their discoveries concerning light-gated ion channels and optogenetics.” The laureates will share the prize amount of 12 million Swedish kronor in equal parts (one-third each) for developing the revolutionary methodology that allows scientists to control cellular and neural circuit activity with millisecond temporal precision using light.
The foundation of optogenetics originates in basic biophysical research on microbial photoreceptors. German biophysicists Peter Hegemann (Humboldt University of Berlin) and Georg Nagel (University of Würzburg) investigated the green alga Chlamydomonas reinhardtii, identifying and characterizing channelrhodopsins—unique light-sensitive transmembrane proteins that function directly as light-gated ion channels. When illuminated with blue light, channelrhodopsins open, permitting the flux of ions across the cell membrane and generating electrical impulses.
Building upon these molecular discoveries, Karl Deisseroth, neuroscientist and bioengineer at Stanford University, pioneered the application of channelrhodopsin in mammalian neurobiology. By introducing the algal gene into mammalian nerve cells, Deisseroth and his team demonstrated that specific neurons could be genetically targeted and reliably activated using pulses of light, first in vitro and subsequently within the intact brains of behaving animal models.
Optogenetics has fundamentally transformed neuroscience from passive observation to direct causal manipulation of defined neural pathways. The technology has provided profound insights into the functional architecture underlying memory consolidation, fear conditioning, motivation, movement disorders, addiction, and psychiatric disease. Beyond foundational neuroscience, optogenetic strategies are driving translational medicine, including clinical efforts exploring gene therapies to restore visual function in degenerative blindness.
Written by: Pragna Biswas
Graphics by: Pramit Hazra
